Dr. Mark Groudine, director of the Basic Sciences Division, is one of 70 scientists elected this year to the Institute of Medicine of the National Academies.
The organization's incumbent member-ship selects new members on the basis of professional achievement and demonstrated interest, concern and involvement with problems and critical issues affecting public health.
Groudine has made crucial contributions to the understanding of how genes are regulated in mammalian cells. He developed techniques for studying gene regulation and discovered elements that help regulate the expression of large regions of chromosomes. In addition to lab research, Groudine, a radiation oncologist, sees patients each week at the University of Washington and is nationally recognized for expertise in oncology.
Among his many accomplishments, Groudine is a member of the National Academy of Sciences, a fellow of the American Association for the Advancement of Science and a recipient of the Allison Eberlein Fund Award, which recognizes major contributions in the field of hematology/oncology. He also served on the Board of Scientific Counselors for the Division of Cancer Treatment of the National Cancer Institute.
The Institute of Medicine, a nonprofit organization chartered in 1970 as a component of the National Academy of Sciences, provides a public service by working outside the framework of government to ensure independent guidance on matters of science and medicine. The institute's mission is to advance and disseminate scientific knowledge to improve human health by providing objective, timely, authori-tative information and advice concerning health and science policy to government, the corporate sector, the professions and the public.
Other institute members at the center include Dr. Ross Prentice, member and former director of the Public Health Sciences Division; Dr. Noel Weiss, PHS; Dr. Norman Breslow, PHS; and Dr. Maureen Henderson, emeritus member of PHS.